Applying CyTOF solutions to cancer immunotherapy clinical trials

It is critical for immunotherapy clinical trials to have an in-depth picture of the immune response to disease and to therapeutic treatments to better identify predictive markers, biomarker translation and understanding mechanism of action.

Explore how CyTOF™ – a single-cell proteomics platform from Standard BioTools – can capture relevant immune metrics and highly multiplexed surface and functional markers simultaneously, to uncover unique biomarkers.